Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 21, 2016; 22(35): 7882-7891
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7882
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7882
Figure 1 Application of biomarkers in ulcerative colitis surveillance protocol.
1Management of LGD is dependent on the clinician and patient choices. HGD: High-grade dysplasia; CRC: Colorectal cancer; LGD: Low-grade dysplasia.
- Citation: Chen R, Lai LA, Brentnall TA, Pan S. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol 2016; 22(35): 7882-7891
- URL: https://www.wjgnet.com/1007-9327/full/v22/i35/7882.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i35.7882